| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |